Shandong Xinhua Pharmaceutical Company Limited ( China (Mainland))

Shandong Xinhua Pharmaceutical Company Limited was established in 1943 as the national largest manufacturing and exporting base in the chemical synthetic pharmaceuticals field,  and is in an leading position in the manufacturing technology and capacity for antipyretics and analgesics in China and is an important manufacturer in China for the drugs for central nervous system, steroids, cardio cerebrovascular system as well as finished dosage forms, pharmaceutical intermediates and pharmaceutical equipment.

Xinhua has been granted the certifications of GMP, ISO9001, ISO14001, and ISO 10012. The main products of Xinhua have been granted the COS Certificate from EDQM and passed the site inspection from USA FDA.

Xinhua is a listing company of H shares and A shares with sound capital structure and product mix. "XINHUA" brand was honored with the title of "Chinese Famous Brand" in China. With the high commitment to the product quality and development of the international markets, Xinhua has established the strategic partnership with dozens of MNCs, the products of Xinhua has been distributed to more than 60 countries and regions.

The products portfolio of Xinhua include chemical products, finished dosages, bulk pharmaceuticals, agrochemical export products. Such as Glyphosate (1071-83-6) , N-Phosphonomethyliminodiaceticacid (5994-61-6), Nicosulfuron (111991-09-4) , Gentamycinsulfateinjection , Amikacinsulfateinjection , TobramycinSulfateInjection , AcetylsalicylicAcid (50-78-2) , Analgin (5907-38-0) and Trimethoprim (738-70-5), etc.